Atlas Trials

Neuronal Ceroid Lipofuscinosis Type 2

2 clinical trials · Condition

Sort:Newest firstOldest first

◉ Watch Neuronal Ceroid Lipofuscinosis Type 2

RecordFirmDate
A First-in-Human, Open-Label, Dose-Escalation Study to Evaluate the Safety and Tolerability of Gene Therapy With TTX-381 for the Ocular Manifestations Associated With Neuronal Ceroid Lipofuscinosis Type 2 (CLN2) Disease (NCT05791864)Tern Therapeutics, LLC2023-05-17
Intravitreal ERT to Prevent Retinal Disease Progression in Children With CLN2 (NCT05152914)David L Rogers, MD2021-11-01

Track Neuronal Ceroid Lipofuscinosis Type 2 automatically

Every clearance here is in the API, with alerts when new ones post.